Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases
- PMID: 12020220
- DOI: 10.1001/archderm.138.5.603
Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases
Abstract
Objective: To study clinical and histological features associated with metastasizing thin melanomas (MTMs).
Design: Case-control study of clinicopathological features of patients with MTMs by a panel of 10 dermatopathologists.
Setting: Members of the North American Melanoma Pathology Study Group selected the cases from the melanoma databases at 8 academic institutions.
Patients: Forty-three patients with MTMs (<1 mm thick) and 42 control subjects without metastasis matched for age, sex, tumor site, and Breslow thickness.
Intervention: None.
Main outcome measures: Clinical (age, sex, site of lesion, stage at diagnosis, metastasis site, disease-free survival, and outcome) and histological (Breslow thickness, Clark level, growth phase, regression, and inflammatory response) features of patients with MTMs vs controls.
Results: There was an overrepresentation of axial tumors among patients with MTMs. Extensive regression was present in 18 patients (42%) with MTM vs 2 matched control subjects (5%) (95% confidence interval, 21%-53%; P =.001). Other histological variables were not significantly different. Two patients had melanomas in situ with subsequent metastasis.
Conclusions: Thin melanomas with extensive regression represent a group at higher risk for the development of metastasis. Furthermore, the risk of metastasis cannot be dismissed in cases of melanoma in situ.
Comment in
-
Thin melanomas and regression, thick melanomas and older men: prognostic implications and perspectives on secondary prevention.Arch Dermatol. 2002 May;138(5):678-82. doi: 10.1001/archderm.138.5.678. Arch Dermatol. 2002. PMID: 12020232 No abstract available.
-
Metastasizing thin melanoma or multiple primary melanomas?Arch Dermatol. 2003 Mar;139(3):388; author reply 388-9. Arch Dermatol. 2003. PMID: 12622646 No abstract available.
Similar articles
-
Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.Ann Surg Oncol. 2012 Jun;19(6):1782-9. doi: 10.1245/s10434-012-2265-y. Epub 2012 Feb 14. Ann Surg Oncol. 2012. PMID: 22350600 Clinical Trial.
-
Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.Am J Surg Pathol. 2018 Mar;42(3):359-366. doi: 10.1097/PAS.0000000000000999. Am J Surg Pathol. 2018. PMID: 29240580
-
Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.Ophthalmic Plast Reconstr Surg. 2003 Mar;19(2):96-101. doi: 10.1097/01.IOP.0000056141.97930.E8. Ophthalmic Plast Reconstr Surg. 2003. PMID: 12644753
-
Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.Melanoma Res. 2007 Dec;17(6):393-9. doi: 10.1097/CMR.0b013e3282f05039. Melanoma Res. 2007. PMID: 17992123
-
Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.Dermatol Surg. 2011 Aug;37(8):1080-8. doi: 10.1111/j.1524-4725.2011.02015.x. Epub 2011 Jun 2. Dermatol Surg. 2011. PMID: 21635622 Review.
Cited by
-
Variations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors.Oncol Lett. 2016 May;11(5):3354-3360. doi: 10.3892/ol.2016.4391. Epub 2016 Mar 29. Oncol Lett. 2016. PMID: 27123116 Free PMC article.
-
Meta-analysis of sentinel lymph node positivity in thin melanoma (<or=1 mm).Cancer. 2009 Feb 15;115(4):869-79. doi: 10.1002/cncr.24044. Cancer. 2009. PMID: 19117354 Free PMC article.
-
Coexistence of regression and tumor infiltrating lymphocytes is associated with more favorable survival in melanoma.J Cancer Res Clin Oncol. 2021 Sep;147(9):2721-2729. doi: 10.1007/s00432-021-03565-y. Epub 2021 Feb 20. J Cancer Res Clin Oncol. 2021. PMID: 33611652 Free PMC article.
-
Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis.Pathol Oncol Res. 2020 Jul;26(3):1861-1868. doi: 10.1007/s12253-019-00769-z. Epub 2019 Dec 2. Pathol Oncol Res. 2020. PMID: 31792874 Free PMC article.
-
Tumoral melanosis without metastasis: a report after three years of follow-up.An Bras Dermatol. 2021 Nov-Dec;96(6):797-798. doi: 10.1016/j.abd.2020.04.016. Epub 2021 Sep 29. An Bras Dermatol. 2021. PMID: 34598805 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical